AAP 2017: Evolve BioSystems to Present Breakthrough Results
Evolve BioSystems is proud to participate in the American Academy of Pediatrics national conference in Chicago, Sept. 16-19, Booth #576
Additionally, Evolve BioSystems will be presenting our latest clinical research showing the ability to restore the infant gut microbiome through supplementation with B. infantis EVC001. The presentation will take place on Friday, Sept 15th from 6-8pm, as part of the Section on Neonatal Perinatal Medicine Program.
The AAP national conference is the most comprehensive pediatric meeting in the world and represents the full spectrum of pediatric medical professionals and decision-makers, including pediatricians in general practice and subspecialties, young physicians, pediatric residents, and other allied health professionals.
Come visit the Evolve booth #576 to learn more about how Evivo (activated B. infantis EVC001) can restore the newborn gut microbiome. These trillions of bacteria that live within the intestinal tract of newborns play a critical role in proper immune and metabolic development as well as meeting the newborn’s nutritional needs. Disruption of the newborn gut microbiome can cause both acute and chronic health consequences. Based on novel discoveries of the unique partnership between mammalian milk and a key intestinal bacterium, Evolve has pioneered a microbiome-based approach to solving newborn gut dysbiosis.
For more details on the AAP national conference, visit: http://aapexperience.org/
Evolve BioSystems Contact
Dr. Tracy Shafizadeh
Director, Scientific Communications